Claims for Patent: 9,265,765

Summary for Patent: 9,265,765

Title:	7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy
Abstract:	This disclosure relates, at least in part, to a method of treatment. In one embodiment, the method of treatment comprises administering to a subject in need of such treatment a first therapeutic agent including compound (1): or a pharmaceutically acceptable salt thereof in combination with a second therapeutic agent, wherein the first therapeutic agent and the second therapeutic agent are administered either simultaneously or sequentially.
Inventor(s):	Martin Stogniew, Joshua E. Allen, Richard S. Pottorf, Bhaskara Rao Nallaganchu, Gary Olson
Assignee:	Provid Pharmaceuticals Inc , Oncoceutics Inc
Application Number:	US14/208,657
Patent Claims:	1. A composition comprising a therapeutic agent including compound (2): 2. A composition for use in a treatment, the composition comprising, separately or together, (i) a first therapeutic agent including compound (1): or a pharmaceutically acceptable salt thereof; and (ii) at least one second therapeutic agent, for simultaneous, sequential or separate administration to a subject in need of such treatment. 3. A composition for use in a treatment, the composition comprising, separately or together, (i) a first therapeutic agent including compound (1): or a pharmaceutically acceptable salt thereof; and (ii) at least one second therapeutic agent, for sequential administration to a subject in need of such treatment, wherein administration of the second therapeutic agent is conditioned on the level of the first therapeutic agent in the subject.